How changes to proteins can alter drug interactions for new precision therapies Scripps Research team maps how chemical modifications to proteins affect drug binding across the human proteome.
May 05, 2026
LA JOLLA, CA Inside every human cell, proteins are constantly being tagged with small chemical modifications after they're produced. Known as post-translational modifications, or PTMs, these can change how a protein folds, where it travels and how it behaves. Now, scientists at Scripps Research have shown that PTMs also play a major role in determining whether proteins can bind to drug-like molecules.
The study, published in Nature Chemical Biology on May 5, 2026, identified more than 400 proteins whose ability to engage drug-like molecules is dictated by their modification state. The findings suggest that the same protein can be more or less druggable depending on which PTMs it carries an insight that could reshape how new therapies are developed.
We already know PTMs affect protein structure and function, says senior author Christopher Parker, a professor and The Abide-Vividion Chair in Chemistry and Chemical Biology at Scripps Research. We asked: if we perturb a class of PTMs, what's the broad impact on proteome-wide druggability?
The team used specially designed chemical probes: small, drug-like molecules that can be locked onto the proteins they bind. By applying these probes in living cells under conditions that altered two of the most common PTMs phosphorylation and N-linked glycosylation the researchers could map which proteins became easier or harder for small molecules to access depending on their modification state.
Of more than 5,000 proteins screened, the affected targets spanned enzymes, ion channels, transcription factors and epigenetic regulators, including many that have historically resisted drugs. In many cases, the PTMs were physically located near the binding sites they affected, directly reshaping pockets that drug-like molecules could occupy. In other cases, PTMs altered how proteins interact with each other, revealing new binding sites in the process.
Among the most consequential findings involved KRAS, one of the most frequently mutated proteins in human cancer and the target of several recently approved drugs, including sotorasib and adagrasib for KRAS G12C-mutant non-small cell lung cancer (NSCLC). The researchers found that phosphorylation at specific sites on KRAS significantly affected how well clinical inhibitors bound and inhibited the protein. This could help explain why KRAS inhibitors don't work equally well across all patients, and suggests a tumor's PTM status could factor into how these therapies are selected or combined.
Even with a small searchlight, we found that one small PTM on one site dramatically affects the activity of known inhibitors for one of the most sought-after drug targets in cancer, says Parker. Those inhibitors work well in patients, but maybe they could work better.
The findings also pointed beyond cancer. Among the targets identified was NPC2, a protein whose malfunction causes Niemann-Pick disease, a rare and fatal condition. In that case, a single sugar-based PTM turned out to determine whether drug-like molecules could bind.
PTMs are another layer of variables that we should be considering more in drug discovery, says Parker.
By identifying which PTM states of a protein are most druggable, researchers may be able to design more selective treatments with fewer off-target effects. Many of the proteins identified in the study lack known drug candidates, which could point to untapped opportunities.
The researchers plan to extend their method to other types of PTMs and to more disease-relevant systems, using larger and more chemically diverse probe libraries to improve coverage of the proteome.
Our vision would be to broadly achieve disease-state-specific pharmacology, says Parker. PTM status could be a way to selectively target a protein in a disease cell, finding vulnerabilities like unique chinks in the armor of a disease.
This study was co-led by staff scientist Weichao Li and graduate student Qijia Wei. In addition to Parker, Li and Wei, authors of Posttranslational modifications remodel proteome-wide ligandability, include Manuel Llanos, Clara Gathmann, Paolo Governa, Tzu-Yuan Chiu, Jacob M. Wozniak, Appaso M. Jadhav, Matthew Holcomb, Jacob Cravatt, Mia L. Huang and Stefano Forli of Scripps Research; and Ashok Dongre of Bristol Myers Squibb.
Support for this study was provided by the National Institute of Allergy and Infectious Diseases (grants R01AI156268 and R01AI182439); the National Institute of General Medical Sciences (grant R35GM142462); and the Chan Zuckerberg Initiative (grant 2023-332369).
Chemistry Parker, Christopher
Europe Stories
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
07/05/2026
January 8, 2024
Colorfront (colorfront.com), a leader in high-performance, on-s...
07/05/2026
February 9, 2024
Colorfront (colorfront.com), the multi-award-winning pioneer i...
07/05/2026
March 20, 2024
NAB 2024, Las Vegas - Colorfront (colorfront.com), the multi-awa...
07/05/2026
April 1, 2025
CINEMACON, APRIL 1, 2025 - Colorfront (colorfront.com), the multi-award-winning developer of high-performance dailies/transcoding/streaming syste...
07/05/2026
June 15, 2025
Colorfront (colorfront.com), an Academy and Emmy Award-winning de...
07/05/2026
June 15, 2025
Colorfront participated in the ICTA Barcelona Cinema Technology Summit on Sunday, June 15, 2025. Held at The Phenomena Experience, the event feat...
07/05/2026
July 1, 2025
Colorfront (colorfront.com), the multi-award-winning developer of high-performance dailies/transcoding/streaming systems for motion pictures, OTT,...
07/05/2026
July 1, 2025
Passion and dedication will take you places. Come with us on a short trip to the heart of India, where Annapurna Studios is living-up to the inspi...
07/05/2026
July 3, 2025
Colorfront (colorfront.com), the multi-award-winning developer of high-performance dailies/transcoding/streaming systems for motion pictures, OTT,...
07/05/2026
September 1, 2025
IBC 2025, Amsterdam - Colorfront (colorfront.com) - the Acade...
07/05/2026
April 17, 2026
LOS ANGELES - April 17, 2026 - Colorfront today announced Colorf...
07/05/2026
April 23, 2026
NAB 2026, Las Vegas - the Academy and Emmy Award-winning develop...
06/05/2026
New pricing tiers for vocal/dialogue restoration tool
NoiseWorks Audio's AI-powered vocal and dialogue processing plug-in is now available in three diff...
06/05/2026
Popular mixing & routing software overhauled
Following a recent public beta test, RME have launched the final release version of the powerful mixing and rou...
06/05/2026
New SOS Video Feature
Focusrites ISA C8X is a milestone product that brings together the companys analogue heritage and their expertise in digital audio. Yo...
06/05/2026
06 May 2026
VEON's Kyivstar Authorized to Resell Starlink for Businesses & ...
06/05/2026
UKTV has secured the exclusive rights to the early back catalogue of iconic Australian drama series Neighbours, following a landmark content deal with Fremantle...
06/05/2026
Wednesday 6 May 2026
Sky commissions feature documentary to mark 10th anniversa...
06/05/2026
Wednesday 6 May 2026
Sky and Formula 1 agree long-term partnership across UK, Ireland and Italy
Sky in the UK & Ireland to remain the home of Formula 1 until ...
06/05/2026
Sky Zero Footprint Fund-backed TV campaign launches nationwide, supported by new...
06/05/2026
Wuppertal May 6, 2026
Riedel Expands Leadership Structure, Appoints Marc Engro...
06/05/2026
SAN JOSE, Calif. - May 6, 2026 - Harmonic (NASDAQ: HLIT) today announced its latest broadband innovations for ANGA COM 2026, highlighting its vision for a new e...
06/05/2026
Statement from Rupert Murdoch, Chairman Emeritus, Fox Corporation on Ted Turner&...
06/05/2026
Friday 8 May on RT One and RT Player
Meet the NSPCA team caring for and protecting animals in need in this six-part series
Fly on the wall, six-part series...
05/05/2026
Experts from the world of academia, tech, business, politics and media convened for a Thomson Talks at the Cambridge Disinformation Summit in April. It's th...
05/05/2026
Another year, and more proof that Asia continues to shape some of the world's most exciting new sounds. This year's RADAR artists draw from deep local r...
05/05/2026
The Austin City Limits Music Fest 2026 lineup just dropped, and this year, Spoti...
05/05/2026
New drum machine book campaign incoming
Bjooks have announced that during Superbooth 2026, they will be launching a Kickstarter campaign to fund the product...
05/05/2026
Flagship all-in-one production bundle updated
The latest version of Native Instruments' flagship virtual instrument and plug-in bundle has just been ann...
05/05/2026
Rohde & Schwarz to host RF Testing Innovations Forum 2026, helping design engine...
05/05/2026
The company grew by 7.6% in net revenue and 16.3% in EBITDA, achieving a 33% inc...
05/05/2026
FOX Sports, FOX One and Indeed Launch Nationwide Search for FOX One Chief World...
04/05/2026
just:play pro 2026 and just:live pro 2026 are available to download!
More Details:At NAB 2026, ToolsOnAir showcased just:play pro 2026 and just:live pro 2026, ...
04/05/2026
just:in mac pro 2026 - The Next Level of Professional Recording on macOS
More Details:The headline innovation in just:in mac pro 2026 is the new Auto format si...
04/05/2026
Last week, guests gathered in New York City for On Air, In Style: An Evening with Spotify-a night of conversation, culture, and connection celebrating the inter...
04/05/2026
New music & post-production features added
Avid's latest DAW update delivers an array of helpful features aimed at both music and post-production users,...
03/05/2026
Polysynth now features Mutable Instruments' macro oscillators
Melbourne Instruments have just released a free firmware update that brings the engine beh...
02/05/2026
Versatile re-amping tool announced
Warm Audio are best known for their recreations of sought-after vintage studio gear, but their latest release brings a ne...
02/05/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
01/05/2026
Florals for spring? Groundbreaking. But a playlist that tells you which The Devi...
01/05/2026
One of the world's biggest popstars is headed to El Cl sico. Later this mont...
01/05/2026
Limited-edition model celebrates 15th anniversary
Heritage Audio's range of monitor controllers has just gained a new member, the Baby RAM Black Edition...
01/05/2026
Dumble recreation now available as UAD plug-in
Along with their renowned processing plug-ins, Universal Audio have been steadily introducing emulations of c...
01/05/2026
We were lucky enough to benefit from huge generosity, so we now have a fantastic Quantum 338T and are developing a cutting-edge d&b loudspeaker system, he expa...
01/05/2026
The first Quantum console purchase made by the company was a Quantum 338 in September 2020. Since then, the company has leveraged Quantum power to steadily expa...
How changes to proteins can alter drug interactions for new precision therapies Scripps Research team maps how chemical modifications to proteins affect drug binding across the human proteome.
